Abstract
The past two decades have witnessed the emergence of a new and expanding field of neurological diseases—the genetic ion channelopathies. These disorders arise from mutations in genes that encode ion channel subunits, and manifest as paroxysmal attacks involving the brain or spinal cord, and/or muscle. The voltage-gated P/Q-type calcium channel (P/Q channel) is highly expressed in the cerebellum, hippocampus and cortex of the mammalian brain. The P/Q channel has a fundamental role in mediating fast synaptic transmission at central and peripheral nerve terminals. Autosomal dominant mutations in the CACNA1A gene, which encodes voltage-gated P/Q-type calcium channel subunit α1 (the principal pore-forming subunit of the P/Q channel) are associated with episodic and progressive forms of cerebellar ataxia, familial hemiplegic migraine, vertigo and epilepsy. This Review considers, from both a clinical and genetic perspective, the various neurological phenotypes arising from inherited P/Q channel dysfunction, with a focus on recent advances in the understanding of the pathogenetic mechanisms underlying these disorders.
Key Points
-
The neuronal voltage-gated P/Q-type calcium channel (P/Q channel) has a fundamental role in synaptic transmission in the human CNS
-
Mutations in CACNA1A, which encodes the α1 subunit of the P/Q channel, are associated with episodic ataxia type 2, familial hemiplegic migraine-1 and spinocerebellar ataxia type 6
-
Loss-of-function mutations in CACNA1A are associated with episodic ataxia type 2; clinical features include intermittent ataxia, headache and vertigo, and acetazolamide (a carbonic anhydrase inhibitor) is an effective treatment
-
Gain-of-function missense mutations in CACNA1A are associated with familial hemiplegic migraine-1
-
Spinocerebellar ataxia type 6 is associated with abnormal expansion of a polyglutamine repeat in the C-terminus of the P/Q channel α1 subunit
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Westenbroek, R. E. et al. Immunochemical identification and subcellular distribution of the α1A subunits of brain calcium channels. J. Neurosci. 15, 6403–6418 (1995).
Diriong, S. et al. Chromosomal localization of the human genes for α1A, α1B, and α1E voltage-dependent Ca2+ channel subunits. Genomics 30, 605–609 (1995).
Jodice, C. et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum. Mol. Genet. 6, 1973–1978 (1997).
McKusick–Nathans Institute of Genetic Medicine, John Hopkins University School of Medicine. OMIM—Online Mendelian Inheritance in Man [online], (2011).
Jouvenceau, A. et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358, 801–807 (2001).
Imbrici, P. et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127, 2682–2692 (2004).
Rajakulendran, S. et al. Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. J. Physiol. 588, 1905–1913 (2010).
Vincent, A. Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems. J. Clin. Immunol. 30 (Suppl. 1), S97–S102 (2010).
Farrugia, M. E. & Vincent, A. Autoimmune mediated neuromuscular junction defects. Curr. Opin. Neurol. 23, 489–495 (2010).
Graus, F. et al. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59, 764–766 (2002).
Spillane, J., Beeson, D. J. & Kullmann, D. M. Myasthenia and related disorders of the neuromuscular junction. J. Neurol. Neurosurg. Psychiatry 81, 850–857 (2010).
Yang, J., Ellinor, P. T., Sather, W. A., Zhang, J. F. & Tsien, R. W. Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channels. Nature 366, 158–161 (1993).
Van Petegem, F., Chatelain, F. C. & Minor, D. L. Jr. Insights into voltage-gated calcium channel regulation from the structure of the CaV1.2 IQ domain–Ca2+/calmodulin complex. Nat. Struct. Mol. Biol. 12, 1108–1115 (2005).
Mochida, S. et al. Requirement for the synaptic protein interaction site for reconstitution of synaptic transmission by P/Q-type calcium channels. Proc. Natl Acad. Sci. USA 100, 2819–2824 (2003).
Rettig, J. et al. Isoform-specific interaction of the α1A subunits of brain Ca2+ channels with the presynaptic proteins syntaxin and SNAP-25. Proc. Natl Acad. Sci. USA 93, 7363–7368 (1996).
Catterall, W. A. Interactions of presynaptic Ca2+ channels and SNARE proteins in neurotransmitter release. Ann. N. Y. Acad. Sci. 868, 144–159 (1999).
Mochida, S., Westenbroek, R. E., Yokoyama, C. T., Itoh, K. & Catterall, W. A. Subtype-selective reconstitution of synaptic transmission in sympathetic ganglion neurons by expression of exogenous calcium channels. Proc. Natl Acad. Sci. USA 100, 2813–2818 (2003).
Catterall, W. A. Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell Dev. Biol. 16, 521–555 (2000).
Catterall, W. A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13–25 (2000).
Jorntell, H. & Hansel, C. Synaptic memories upside down: bidirectional plasticity at cerebellar parallel fiber–Purkinje cell synapses. Neuron 52, 227–238 (2006).
Higley, M. J. & Sabatini, B. L. Calcium signaling in dendrites and spines: practical and functional considerations. Neuron 59, 902–913 (2008).
Kongsamut, S., Lipscombe, D. & Tsien, R. W. The N-type Ca channel in frog sympathetic neurons and its role in α-adrenergic modulation of transmitter release. Ann. N. Y. Acad. Sci. 560, 312–333 (1989).
Bourinet, E. et al. Splicing of α1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat. Neurosci. 2, 407–415 (1999).
Tsunemi, T. et al. Novel CaV2.1 splice variants isolated from Purkinje cells do not generate P-type Ca2+ current. J. Biol. Chem. 277, 7214–7221 (2002).
Soong, T. W. et al. Systematic identification of splice variants in human P/Q-type channel α1(2.1) subunits: implications for current density and Ca2+-dependent inactivation. J. Neurosci. 22, 10142–10152 (2002).
Graves, T. D. et al. Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2. Neurobiol. Dis. 32, 10–15 (2008).
Zhuchenko, O. et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat. Genet. 15, 62–69 (1997).
Ishikawa, K. et al. Abundant expression and cytoplasmic aggregations of α1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 8, 1185–1193 (1999).
Romaniello, R. et al. A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J. Neurol. Neurosurg. Psychiatry 81, 840–843 (2010).
Parker, H. L. Periodic ataxia. Collect. Papers Mayo Clinic Mayo Found. 38, 642–645 (1946–1947).
Ophoff, R. A. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87, 543–552 (1996).
Jen, J. C. et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 130, 2484–2493 (2007).
Jen, J., Kim, G. W. & Baloh, R. W. Clinical spectrum of episodic ataxia type 2. Neurology 62, 17–22 (2004).
Baloh, R. W., Yue, Q., Furman, J. M. & Nelson, S. F. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann. Neurol. 41, 8–16 (1997).
Riant, F., Mourtada, R., Saugier-Veber, P. & Tournier-Lasserve, E. Large CACNA1A deletion in a family with episodic ataxia type 2. Arch. Neurol. 65, 817–820 (2008).
Imbrici, P. et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 65, 944–946 (2005).
Engel, K. C., Anderson, J. H., Gomez, C. M. & Soechting, J. F. Deficits in ocular and manual tracking due to episodic ataxia type 2. Mov. Disord. 19, 778–787 (2004).
Sasaki, O. et al. Neurotological findings in a family with episodic ataxia. J. Neurol. 250, 373–375 (2003).
Jen, J. et al. Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57, 1843–1848 (2001).
Melzer, N., Classen, J., Reiners, K. & Buttmann, M. Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q. J. Neurol. Sci. 296, 104–106 (2010).
Spacey, S. D., Materek, L. A., Szczygielski, B. I. & Bird, T. D. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch. Neurol. 62, 314–316 (2005).
Roubertie, A. et al. Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. J. Neurol. 255, 1600–1602 (2008).
Eunson, L. H., Graves, T. D. & Hanna, M. G. New calcium channel mutations predict aberrant RNA splicing in episodic ataxia. Neurology 65, 308–310 (2005).
Mochizuki, Y. et al. Hereditary paroxysmal ataxia with mental retardation: a clinicopathological study in relation to episodic ataxia type 2. Acta Neuropathol. 108, 345–349 (2004).
Vighetto, A., Froment, J. C., Trillet, M. & Aimard, G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch. Neurol. 45, 547–549 (1988).
Hawkes, C. H. Familial paroxysmal ataxia: report of a family. J. Neurol. Neurosurg. Psychiatry 55, 212–213 (1992).
Bain, P. G., O'Brien, M. D., Keevil, S. F. & Porter, D. A. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann. Neurol. 31, 147–154 (1992).
Harno, H. et al. Decreased cerebellar total creatine in episodic ataxia type 2: a 1H MRS study. Neurology 64, 542–544 (2005).
Vahedi, K. et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann. Neurol. 37, 289–293 (1995).
Kramer, P. L. et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am. J. Hum. Genet. 57, 182–185 (1995).
von Brederlow, B., Hahn, A. F., Koopman, W. J., Ebers, G. C. & Bulman, D. E. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum. Mol. Genet. 4, 279–284 (1995).
Mantuano, E. et al. Clusters of non-truncating mutations of P/Q type Ca2+ channel subunit CaV2.1 causing episodic ataxia 2. J. Med. Genet. 41, e82 (2004).
Jen, J. C. & Baloh, R. W. Genetics of episodic ataxia. Adv. Neurol. 89, 459–461 (2002).
Guida, S. et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68, 759–764 (2001).
Strupp, M., Zwergal, A. & Brandt, T. Episodic ataxia type 2. Neurotherapeutics 4, 267–273 (2007).
Wan, J., Carr, J. R., Baloh, R. W. & Jen, J. C. Nonconsensus intronic mutations cause episodic ataxia. Ann. Neurol. 57, 131–135 (2005).
Labrum, R. W. et al. Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. J. Med. Genet. 46, 786–791 (2009).
Riant, F. et al. Identification of CACNA1A large deletions in four patients with episodic ataxia. Neurogenetics 11, 101–106 (2010).
Veneziano, L. et al. Newly characterised 5′ and 3′ regions of CACNA1A gene harbour mutations associated with familial hemiplegic migraine and episodic ataxia. J. Neurol. Sci. 276, 31–37 (2009).
Mantuano, E. et al. Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J. Neurol. Sci. 291, 30–36 (2010).
Page, K. M. et al. N terminus is key to the dominant negative suppression of CaV2 calcium channels: implications for episodic ataxia type 2. J. Biol. Chem. 285, 835–844 (2010).
Jeng, C. J., Sun, M. C., Chen, Y. W. & Tang, C. Y. Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels. J. Cell. Physiol. 214, 422–433 (2008).
Raike, R. S., Kordasiewicz, H. B., Thompson, R. M. & Gomez, C. M. Dominant-negative suppression of CaV2.1 currents by α12.1 truncations requires the conserved interaction domain for β subunits. Mol. Cell. Neurosci. 34, 168–177 (2007).
Page, K. M. et al. Dominant-negative calcium channel suppression by truncated constructs involves a kinase implicated in the unfolded protein response. J. Neurosci. 24, 5400–5409 (2004).
Mezghrani, A. et al. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. J. Neurosci. 28, 4501–4511 (2008).
Cao, Y. Q. et al. Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy. Neuron 43, 387–400 (2004).
Maselli, R. A. et al. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 61, 1743–1748 (2003).
Walter, J. T., Alviña, K., Womack, M. D., Chevez, C. & Khodakhah, K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat. Neurosci. 9, 389–397 (2006).
Pietrobon, D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr. Opin. Neurobiol. 15, 257–265 (2005).
Seemungal, B. M., Gresty, M. A. & Bronstein, A. M. The endocrine system, vertigo and balance. Curr. Opin. Neurol. 14, 27–34 (2001).
Helmich, R. C. et al. The dynamic regulation of cortical excitability is altered in episodic ataxia type 2. Brain 133, 3519–3529 (2010).
Harno, H. et al. Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2). J. Neurol. 251, 232–234 (2004).
Griggs, R. C., Moxley, R. T. 3rd, Lafrance, R. A. & McQuillen, J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 28, 1259–1264 (1978).
Calandriello, L. et al. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain 120, 805–812 (1997).
Spacey, S. D., Hildebrand, M. E., Materek, L. A., Bird, T. D. & Snutch, T. P. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann. Neurol. 56, 213–220 (2004).
Strupp, M. et al. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62, 1623–1625 (2004).
Strupp, M. et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77, 269–275 (2011).
Dieterich, M. & Brandt, T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J. Neurol. 246, 883–892 (1999).
Furman, J. M., Marcus, D. A. & Balaban, C. D. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr. Opin. Neurol. 16, 5–13 (2003).
Neuhauser, H., Leopold, M., von Brevern, M., Arnold, G. & Lempert, T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56, 436–441 (2001).
Murdin, L., Davies, R. A. & Bronstein, A. M. Vertigo as a migraine trigger. Neurology 73, 638–642 (2009).
Browne, D. L. et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8, 136–140 (1994).
Litt, M. et al. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am. J. Hum. Genet. 55, 702–709 (1994).
Eunson, L. H. et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann. Neurol. 48, 647–656 (2000).
Rajakulendran, S., Schorge, S., Kullmann, D. M. & Hanna, M. G. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics 4, 258–266 (2007).
Escayg, A. et al. Coding and noncoding variation of the human calcium-channel β4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Genet. 66, 1531–1539 (2000).
Graves, T. D. & Hanna, M. G. Episodic ataxia: SLC1A3 and CACNB4 do not explain the apparent genetic heterogeneity. J. Neurol. 255, 1097–1099 (2008).
Cader, M. Z., Steckley, J. L., Dyment, D. A., McLachlan, R. S. & Ebers, G. C. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 65, 156–158 (2005).
Farmer, T. W. & Mustian, V. M. Familial periodic vertigo, diplopia, and ataxia. Trans. Am. Neurol. Assoc. 87, 86–90 (1962).
Damji, K. F. et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch. Neurol. 53, 338–344 (1996).
Meisler, M. H., Kearney, J., Escayg, A., MacDonald, B. T. & Sprunger, L. K. Sodium channels and neurological disease: insights from Scn8a mutations in the mouse. Neuroscientist 7, 136–145 (2001).
Jen, J. C., Wan, J., Palos, T. P., Howard, B. D. & Baloh, R. W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65, 529–534 (2005).
de Vries, B. et al. Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. Arch. Neurol. 66, 97–101 (2009).
Kerber, K. A., Jen, J. C., Lee, H., Nelson, S. F. & Baloh, R. W. A new episodic ataxia syndrome with linkage to chromosome 19q13. Arch. Neurol. 64, 749–752 (2007).
Cha, Y. H. et al. Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q. J. Neurol. Neurosurg. Psychiatry 78, 1273–1275 (2007).
Ducros, A. et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med. 345, 17–24 (2001).
Thomsen, L. L., Olesen, J. & Russell, M. B. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur. J. Neurol. 10, 421–427 (2003).
Ducros, A. et al. Mapping of a second locus for familial hemiplegic migraine to 1q21–q23 and evidence of further heterogeneity. Ann. Neurol. 42, 885–890 (1997).
Pietrobon, D. Familial hemiplegic migraine. Neurotherapeutics 4, 274–284 (2007).
Kors, E. E. et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol. 49, 753–760 (2001).
De Fusco, M. et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192–196 (2003).
Riant, F. et al. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum. Mutat. 26, 281 (2005).
Dichgans, M. et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366, 371–377 (2005).
Tottene, A. et al. Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl Acad. Sci. USA 99, 13284–13289 (2002).
Hans, M. et al. Functional consequences of mutations in the human α1A calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci. 19, 1610–1619 (1999).
van den Maagdenberg, A. M. et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41, 701–710 (2004).
Omata, T., Takanashi, J., Wada, T., Arai, H. & Tanabe, Y. Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine. Brain Dev. 33, 332–334 (2011).
Battistini, S. et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 53, 38–43 (1999).
Jen, J. C. Familial hemiplegic migraine. GeneReviews, NCBI Bookshelf, US National Library of Medicine, NIH [online], (2009).
Yu-Wai-Man, P., Gorman, G., Bateman, D. E., Leigh, R. J. & Chinnery, P. F. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J. Neurol. 256, 78–82 (2009).
Craig, K., Keers, S. M., Archibald, K., Curtis, A. & Chinnery, P. F. Molecular epidemiology of spinocerebellar ataxia type 6. Ann. Neurol. 55, 752–755 (2004).
Gomez, C. M. et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann. Neurol. 42, 933–950 (1997).
Hashimoto, T., Sasaki, O., Yoshida, K., Takei, Y. & Ikeda, S. Periodic alternating nystagmus and rebound nystagmus in spinocerebellar ataxia type 6. Mov. Disord. 18, 1201–1204 (2003).
Matsuyama, Z. et al. Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in spinocerebellar ataxia 6. J. Neurosci. 19, RC14 (1999).
Piedras-Renteria, E. S. et al. Increased expression of α1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6. J. Neurosci. 21, 9185–9193 (2001).
Restituito, S. et al. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a β subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. J. Neurosci. 20, 6394–6403 (2000).
Watase, K. et al. Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc. Natl Acad. Sci. USA 105, 11987–11992 (2008).
Liu, J. et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J. Neurosci. 29, 9148–9162 (2009).
Schorge, S., van de Leemput, J., Singleton, A., Houlden, H. & Hardy, J. Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signalling. Trends Neurosci. 33, 211–219 (2010).
Khosravani, H. & Zamponi, G. W. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol. Rev. 86, 941–966 (2006).
Miki, T. et al. Two novel alleles of tottering with distinct CaV2.1 calcium channel neuropathologies. Neuroscience 155, 31–44 (2008).
Zwingman, T. A., Neumann, P. E., Noebels, J. L. & Herrup, K. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J. Neurosci. 21, 1169–1178 (2001).
Noebels, J. L. & Sidman, R. L. Inherited epilepsy: spike-wave and focal motor seizures in the mutant mouse tottering. Science 204, 1334–1336 (1979).
Fletcher, C. F. et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87, 607–617 (1996).
Fletcher, C. F. & Frankel, W. N. Ataxic mouse mutants and molecular mechanisms of absence epilepsy. Hum. Mol. Genet. 8, 1907–1912 (1999).
Lorenzon, N. M., Lutz, C. M., Frankel, W. N. & Beam, K. G. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner. J. Neurosci. 18, 4482–4489 (1998).
Neufeld, M. Y., Nisipeanu, P., Chistik, V. & Korczyn, A. D. The electroencephalogram in acetazolamide-responsive periodic ataxia. Mov. Disord. 11, 283–288 (1996).
Van Bogaert, P. & Szliwowski, H. B. EEG findings in acetazolamide-responsive hereditary paroxysmal ataxia. Neurophysiol. Clin. 26, 335–340 (1996).
Beauvais, K. et al. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol. 52, 58–61 (2004).
Kors, E. E. et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63, 1136–1137 (2004).
Gourfinkel-An, I. et al. Monogenic idiopathic epilepsies. Lancet Neurol. 3, 209–218 (2004).
Chioza, B. et al. Association between the α1A calcium channel gene CACNA1A and idiopathic generalized epilepsy. Neurology 56, 1245–1246 (2001).
Cavalleri, G. L. et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case–control study. Lancet Neurol. 6, 970–980 (2007).
Sander, T., Toliat, M. R., Heils, A., Becker, C. & Nürnberg, P. Failure to replicate an allelic association between an exon 8 polymorphism of the human α1A calcium channel gene and common syndromes of idiopathic generalized epilepsy. Epilepsy Res. 49, 173–177 (2002).
Helbig, I., Scheffer, I. E., Mulley, J. C. & Berkovic, S. F. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol. 7, 231–245 (2008).
Lapie, P., Goudet, C., Nargeot, J., Fontaine, B. & Lory, P. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle α 1s subunit as expressed in mouse L cells. FEBS Lett. 382, 244–248 (1996).
Morrill, J. A. & Cannon, S. C. Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes. J. Physiol. 520, 321–336 (1999).
Jurkat-Rott, K., McCarthy, T. & Lehmann-Horn, F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23, 4–17 (2000).
Splawski, I. et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004).
Splawski, I. et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl Acad. Sci. USA 102, 8089–8096 (2005).
Liao, P. & Soong, T. W. CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch. 460, 353–359 (2010).
Striessnig, J., Bolz, H. J. & Koschak, A. Channelopathies in CaV1.1, CaV1.3, and CaV1.4 voltage-gated L-type Ca2+ channels. Pflugers Arch. 460, 361–374 (2010).
Strom, T. M. et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 260–263 (1998).
McRory, J. E. et al. The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution. J. Neurosci. 24, 1707–1718 (2004).
Evans, R. M. & Zamponi, G. W. Presynaptic Ca2+ channels—integration centers for neuronal signaling pathways. Trends Neurosci. 29, 617–624 (2006).
Perez-Reyes, E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol. Rev. 83, 117–161 (2003).
Perez-Reyes, E. Molecular characterization of T-type calcium channels. Cell Calcium 40, 89–96 (2006).
Iftinca, M. C. & Zamponi, G. W. Regulation of neuronal T-type calcium channels. Trends Pharmacol. Sci. 30, 32–40 (2009).
Zamponi, G. W., Lory, P. & Perez-Reyes, E. Role of voltage-gated calcium channels in epilepsy. Pflugers Arch. 460, 395–403 (2010).
Acknowledgements
The authors' research work is supported by the Wellcome Trust (S. Rajakulendran), the Medical Research Council and Action Medical Research (M. G. Hanna). Part of this work was undertaken at University College Hospital, University College London, UK, which receives a proportion of its funding from the National Institute for Health Research Biomedical Research Center. M. G. Hanna is supported by Medical Research Council grant number G0601943.
Author information
Authors and Affiliations
Contributions
All three authors wrote the manuscript. S. Rajakulendran and D. Kaski researched data for the article, S. Rajakulendran contributed to discussions of the content, and S. Rajakulendran and M. G. Hanna undertook review and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rajakulendran, S., Kaski, D. & Hanna, M. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol 8, 86–96 (2012). https://doi.org/10.1038/nrneurol.2011.228
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.228
This article is cited by
-
P/Q type (Cav2.1) Calcium Channel Blocker ω-Agatoxin IVA Alters Cleaved Caspase-3 and BDNF Expressions in the Rat Brain and Suppresses Seizure Activity
Molecular Neurobiology (2024)
-
Molecular Mechanisms of Epilepsy: The Role of the Chloride Transporter KCC2
Journal of Molecular Neuroscience (2022)
-
The CACNA1A Mutant Disrupts Lysosome Calcium Homeostasis in Cerebellar Neurons and the Resulting Endo-Lysosomal Fusion Defect Can be Improved by Calcium Modulation
Neurochemical Research (2022)
-
Whole-exome sequencing of Finnish patients with vascular cognitive impairment
European Journal of Human Genetics (2021)
-
Resolving molecular contributions of ion channel noise to interspike interval variability through stochastic shielding
Biological Cybernetics (2021)